module a: clinical research coordinator roles and responsibilities
DESCRIPTION
MODULE A: Clinical Research Coordinator Roles and Responsibilities. Denise K. Thwing, MAS, RN, CCRA Associate Director Project Management. Key Players. Ideal Characteristics. Scientific/medical background Interest in advancing medical needs of patients Interest in research Detail oriented - PowerPoint PPT PresentationTRANSCRIPT
Version: Final 24-Mar-2010 1
MODULE A:Clinical Research Coordinator
Roles and Responsibilities
Denise K. Thwing, MAS, RN, CCRAAssociate Director Project
Management
Version: Final 24-Mar-2010 2
Key Players
Clinical Research
Coordinator
Subjects/families
Sponsor
IRB
PI/Sub-Is
Version: Final 24-Mar-2010 3
Ideal Characteristics Scientific/medical background Interest in advancing medical needs of
patients Interest in research Detail oriented Organizational Skills Ability to multi-task People skills Communication skills Creative and Flexible
Version: Final 24-Mar-2010 4
Roles and Responsibilities The definition of a CRC as per the
Association of Clinical Research Professionals is: “A Clinical Research Coordinator, Study Site Research Nurse or Study Site Coordinator works at a clinical research site under the direction of a principle investigator, whose research activities are conducted under Good Clinical Practice regulations.
Version: Final 24-Mar-2010 5
Roles and Responsibilities Roles and responsibilities have not been
formally described in the ICH-GCP guidelines. Their role remains vague and ill defined.
CRC responsibilities vary greatly from institution to institution.
Responsibilities depend on what is delegated by the Investigator.
Version: Final 24-Mar-2010 6
Roles and Responsibilities Administrative Duties
Protocol feasibility for the site Incidence and prevalence rates for major diseases Contracts
Budgets per institution/sponsor Assist/Complete IRB documents
Completion of required templates Interacts regularly with PIs, IRBs, Sponsors,
CRAs, Clinics, Pharmacies, Radiology Facilities, etc. Know your hours of operation, clinic schedule, PI,
sub-I availability Maintain contact information
Version: Final 24-Mar-2010 7
Roles and Responsibilities Maintain Documents
IRB Correspondence/ICFs
Source documents
CRFs/eCRFs
CVs, local lab certificates
Study reference manual
Version: Final 24-Mar-2010 8
Roles and Responsibilities Coordinate/participate in Monitoring visits
Ensure all materials are prepared for reviewSecond QC ideal
Reserve space for CRAs/sponsors
Allow time to spend with CRAs to make corrections/reply to DCFs
Coordinate activities staff
Version: Final 24-Mar-2010 9
Roles and ResponsibilitiesSet-up and maintain
documents
Coordinate MVs
Facilitate Site Audits
Interact with subjects
Maintain site training
Version: Final 24-Mar-2010 10
Roles and Responsibilities Interactions with Subjects/families
Recruit/screen IRB approved advertising/posters/TV/Radio
Consent Verify all elements are present Verify correct version
Conduct study visit procedures Know your protocol Verify CRF captures all data in the protocol Drug dispensing/accountability
Retention/follow-up/study reminder appt cards/calendars
Version: Final 24-Mar-2010 11
Roles and Responsibilities 1.1 Time and Events Schedule
(a) Complete vital signs, including height (Visit 1 only), weight, respiratory rate, temperature, and orthostatic (sitting, immediate standing and 2-minute standing) blood pressure and pulse rate measurements. (b) Subjects will be administered one ECG at Visits 1 and Day 2; subjects will be instructed to remain in a supine position 2 minutes prior to each ECG evaluation. (c) Echocardiogram should be scheduled 2 weeks prior to Visit 3 to insure results are available for review at this visit. (d) First 24 hour urine collection to begin 24 hours prior to dose and second 24 hour urine collection to begin at time of dose. Urine samples will be collected and labeled at 2, 4 and 24 hour increments. (e)Visit 1 clinical laboratory tests will include chemistry, hematology, endocrinology, urinalysis, and HIV, Hep B & C antibody screen. Day 1and Day 2 clinical laboratory tests will include chemistry, hematology, endocrinology, and urinalysis as well as plasma rennin, aldosterone, pharmacokinetics and (baseline/predose, 0.25 hr, 0.5 hr, 1 hr, 2 hr, 4 hr, 6 hr, 8 hr, 12 hr and 24 hr), baseline sample for anti-PL-3994 antibody formation and 24 hour urine (including measurement of electrolytes). Eight week follow-up clinical laboratory test will include chemistry, urinalysis, as well as an analysis for potential antibody formation. Samples for immunology analysis will be batched and processed at the end of the study.
(f) Dosing will begin with two of the four subjects in the first cohort. Dosing for the next two subjects will begin 2 hours after the first two subjects are dosed.
(g) The monitor will be set to take a measurement at baseline, 5 minutes, 10 minutes, 15 minutes, 20 minutes, 30 minutes and then every 15 minutes. Should a clinically significant change in blood pressure be detected, it must be confirmed with a manual cuff measurement within 5 minutes.Subjects should be encouraged to remain comfortably seated to the extent possible during the 8 hour period, except as required by other study procedures.
Evaluations
Visit 1
(Screening Day -21)
Visit 2 Visit 3 30 days
Follow Up (+ 3 days)
Day -2
Day -1 Day 1 Day 2
Informed Consent X Medical History X Physical Examination X X Vital Signs(a) X X X X X 12-Lead Resting ECG(b) X X X Echocardiogram(c) X X Continuous Urine Collection(d) X X X Urinalysis for Drugs of Abuse X X Clinical Laboratory Tests(e) X X X X Verify Inclusion & Exclusion Criteria X X Record Fluid and Food Intake X X X X Administer Study Drug(f) X Continuous Blood Pressure Monitoring Post-Dose (≥8 hours post-dose)
X
Record Concomitant Drug Usage X X X X X X AE Assessment X X X X X
Version: Final 24-Mar-2010 12
Roles and Responsibilities Challenges
On time patient visit schedule Clinic space Investigator availability Time to record legible data, review for accuracy/
answer DCFs Diary compliance Lab assessments/difficult sticks Initial and ongoing assessment lab/clinical data
Change from baseline/causesAbnormal values/why?Ensure patient compliance with protocol/deviations
Version: Final 24-Mar-2010 13
Roles and Responsibilities A survey of trial subjects showed that
listening, providing information and answering questions from subjects are some of the most important aspects of the role of the CRC.
In one survey where study subjects reported an excellent relationship with the CRC, more than 88% felt that the CRC positively influenced their participation in the trial. The CRC/subject relationship positively influenced
subject compliance. J.Obstet.Gynecol Neonal Nursing:1997 May-Jun; 26 (3): 279-85
Version: Final 24-Mar-2010 14
Roles and Responsibilities Laboratory
Obtain/prepare samples Know protocol samples/time points
Know refrigerator/freezer requirements
OHSA regulations
Know courier/package, country requirements and pick-up locations/times
IATA certification www.iata.org CLIA – Clinical Laboratory Improvement Amendments CAP – College of American Pathologists
Version: Final 24-Mar-2010 15
Roles and Responsibilities Personal Responsibilities
Training/stay currentGCP/ICH yearlyAttend conferences/accreditation/ACRP/SoCRAIRB policies and procedureswww.fda.gov
Reference room: Code of Federal Regulations